A manufacturer’s responsibility in producing and assessing biosimilars

• In: Pre-Congress Satellite on Biosimilars: The Science, Regulation, Practice, Education of Follow-on Biologic Pharmaceuticals on Saturday, 1 September 2018, 09:00-17:30
• At: Glasgow (Scotland) (2018)
• Type: Presentation
• By: GAUVIN, Gay (Global Operations Director Biosimilars, Amgen)
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login